Evidence map›Paper›PMID 37907991›Full record

ArticleJournal of translational medicine2023

Changes of immune microenvironment in head and neck squamous cell carcinoma in 3D-4-culture compared to 2D-4-culture.

Jian Xiao, Yexun Song, Ru Gao, Mingyang You, Changxin Deng, Guolin Tan, Wei Li

Open access · goldAbstract read
In one paragraph

Article in Journal of translational medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Gene Expression ofIn vivo (Athens, Greece)
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jian XiaoDepartment of Otolaryngology-Head and Neck Surgery, The Third Xiangya Hospital of Central South University, Changsha, 410013, China.
Yexun SongDepartment of Otolaryngology-Head and Neck Surgery, The Third Xiangya Hospital of Central South University, Changsha, 410013, China.
Ru GaoDepartment of Otolaryngology-Head and Neck Surgery, The Third Xiangya Hospital of Central South University, Changsha, 410013, China.
Mingyang YouDepartment of Otolaryngology-Head and Neck Surgery, The Third Xiangya Hospital of Central South University, Changsha, 410013, China.
Changxin DengDepartment of Otolaryngology-Head and Neck Surgery, The Third Xiangya Hospital of Central South University, Changsha, 410013, China.
Guolin TanDepartment of Otolaryngology-Head and Neck Surgery, The Third Xiangya Hospital of Central South University, Changsha, 410013, China.
Wei LiDepartment of Otolaryngology-Head and Neck Surgery, The Third Xiangya Hospital of Central South University, Changsha, 410013, China. lilywei1979@126.com.ORCID 0000-0001-9911-2384
Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe immune system plays a crucial role in initiating, progressing, and disseminating HNSCC. This study aims to investigate the differences in immune microenvironments between 2D-4-culture and 3D-4-culture models of head and neck squamous cell carcinoma (HNSCC) cells (FaDu), human fibroblasts (HF), human monocytes (THP-1), and human endothelial cells (HUVEC).

methodsFor the 3D-4-culture model, FaDu:HF:THP-1 (2:1:1) were inoculated in an ultra-low attachment culture plate, while HUVECs were placed in a transwell chamber. The ordinary culture plate was used for the 2D-4-culture model. Tumor-associated macrophage markers (CD163), tumor-associated fibroblast markers (FAP), and epithelial-mesenchymal transition (EMT) were detected by western blot. Inflammatory cytokines (IL-4, IL-2, CXCL 10, IL-1 β, TNF-α, CCL 2, IL-17 A, IL-6, IL-10, IFN-γ, IL-12 p 70, CXCL 8, TGFβ1) in the supernatant were measured by flow cytometry. HUVEC migration was observed under a microscope. The 3D spheres were stained and observed with a confocal microscope. CCK8 assay was used to detect the resistance of mixed cells to cisplatin in both 2D-4-culture and 3D-4-culture.

resultsAfter three days of co-culture, the 3D-4-culture model showed increased expression levels of CD163 and FAP proteins (both P < 0.001), increased expression of E-cadherin protein and N-cadherin protein expression (P < 0.001), decreased expression of vimentin (P < 0.01) and Twist protein (P < 0.001). HUVEC migration significantly increased (P < 0.001), as did the concentrations of IP-10, MCP-1, IL-6, and IL-8 (all P < 0.001). Confocal microscopy showed that 3D-4-culture formed loose cell clusters on day 1, which gradually became a dense sphere surrounded by FaDu cells invading the inside. After co-culturing for 24 h, 48 h, and 72 h, the resistance of mix cells to cisplatin in 3D-4-culture was significantly higher than in 2D-4-culture (P < 0.01 for all).

conclusionCompared to 2D-4-culture, 3D-4-culture better simulates the in vivo immune microenvironment of HNSCC by promoting fibroblast transformation into tumor-associated fibroblasts, monocyte transformation into tumor-associated macrophages, enhancing endothelial cell migration ability, partial EMT formation in HNSCC cells, and is more suitable for studying the immunosuppressive microenvironment of HNSCC.

Indexed as

Carcinoma, Squamous CellHead and Neck NeoplasmsCell Line, TumorCisplatinEndothelial CellsEpithelial-Mesenchymal TransitionHumansInterleukin-6Squamous Cell Carcinoma of Head and NeckTranscription FactorsTumor MicroenvironmentCisplatinInterleukin-6Transcription Factors2D-4-culture3D-4-cultureHead and neck squamous cell carcinomaImmune microenvironment

Identifiers

PMID37907991
PMCPMC10617167
OpenAlexW4388043089

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.